Nemysis has a total of 30 patents globally, out of which 11 have been granted. Of these 30 patents, more than 80% patents are active. Italy, Europe (EPO), United States of America is where Nemysis has filed the maximum number of patents. Parallelly, Italy seems to be the main focused R&D centre and also Ireland is the origin country of Nemysis.
Nemysis was founded in 2015. Operator specializes in addressing nutritional disorders with novel products: a gastric-resistant glutenous for celiac disease therapy, and an iron supplement with a gluten-destroying medical device, preventing symptoms in celiac and gluten-sensitive patients, reducing gastrointestinal side effects during iron supplementation.
Do read about some of the most popular patents of Nemysis which have been covered by us in this article and also you can find Nemysis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Nemysis patent portfolio.
How many patents does Nemysis have?
Nemysis has a total of 30 patents globally. These patents belong to 10 unique patent families. Out of 30 patents, 24 patents are active.
How Many Patents did Nemysis File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Nemysis Applications Filed | Nemysis Patents Granted |
| 2023 | 1 | – |
| 2022 | 3 | 1 |
| 2021 | 3 | 2 |
| 2020 | 8 | 2 |
| 2019 | 1 | 2 |
| 2018 | – | 3 |
| 2016 | 2 | 1 |
| 2015 | 11 | – |
| 2014 | 1 | – |
How many Nemysis patents are Alive/Dead?
Worldwide Patents
How Many Patents did Nemysis File in Different Countries?
Countries in which Nemysis Filed Patents
| Country | Patent |
| Italy | 3 |
| Europe (EPO) | 3 |
| United States of America | 3 |
| Brazil | 2 |
| China | 2 |
| Canada | 2 |
| India | 2 |
| United Kingdom | 1 |
| Spain | 1 |
| Australia | 1 |
| Denmark | 1 |
| Turkey | 1 |
| Japan | 1 |
| Hong Kong (S.A.R.) | 1 |
| Portugal | 1 |
| Russian Federation | 1 |
Where are Research Centers of Nemysis Patents Located?
What Percentage of Nemysis US Patent Applications Were Granted?
Nemysis (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Nemysis patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Nemysis?
| Law Firm | Total Applications | Success Rate |
| Mcneill Baur Pllc | 1 | 0% |
| Silvia Salvadori PC | 1 | 0% |
| Stetina Brunda Garred & Brucker | 1 | 100.00% |
List of Nemysis patents
| Nemysis Patents | Title |
| US10709787B2 | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| US20230134391A1 | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases |
| US20220364069A1 | Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase |
| EP3139961B1 | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| EP4132506A1 | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases |
| EP4004199A1 | Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase |
| CN106488772B | Hydrogel Of Methacrylic Acid Hyaluronic Acid Derivative For Oral Enzyme Therapy Of Celiac |
| CN114174519A | Method For Producing An Enzyme Composition Comprising A Recombinant Endopeptidase |
| WO2023285135A1 | New Systems For Producing Recombinant Proteins |
| WO2021204705A1 | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases |
| WO2021013553A1 | Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase |
| CA2946811C | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| CA3143903A1 | Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase |
| AU2020318422A1 | Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase |
| JP06532483B2 | Hydrogel Of The Methacryl Hyaluronic Acid Derivative For The Oral Enzyme Treatment Of The Celiac Disease |
| IN365053B | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| RU2679638C2 | Hydrogels Of Methacryl Derivatives Of Hyaluronic Acid For Oral Enzymatic Therapy Of Gluten Enteropathy |
| DK3139961T3 | Hydrogels Of Methacryl Hyaluronic Acid Derivatives For Oral Enzymy Therapy |
| ES2675574T3 | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| IT2019000012942B1 | Method For The Production Of An Enzymatic Composition Including A Recombinant Endopeptidase |
| IT1423638B1 | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease. |
| IN202024004527A | Method For The Production Of An Enzymatic Composition Comprising A Recombinant Endopeptidase |
| BR112022000954A2 | A Method For Producing An Enzyme Composition Comprising A Recombinant Endopeptidase |
| BR112016026039A2 | Hydrogels Of Methacrylic Derivatives Of Hyaluronic Acid For Enzymatic Oral Therapy Of A Celiac Disease |
| HK40087350A | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases |
| IT202100018254A1 | New Systems For Producing Recombinant Proteins |
| PT3139961T | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| TR201809421T4 | Hydrojels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease. |
| WO2015169849A1 | Hydrogels Of Methacrylic Hyaluronic Acid Derivatives For Oral Enzyme Therapy In Celiac Disease |
| GB202005054D0 | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions For Use In The Treatment Or Prevention Of Iron Deficiency Associated With Liver Diseases |
What are Nemysis key innovation segments?
What Technologies are Covered by Nemysis?
The chart below distributes patents filed by Nemysis